RJ Gralla, D Osoba, MG Kris, P Kirkbride, PJ … - Journal of Clinical Oncology, 1999 - jco.ascopubs.org THE GOAL OF ANTIEMETIC therapy is to prevent nausea and vomiting completely.
This goal is achieved for many patients receiving chemotherapy or radiation
therapy, and is based on clinical and basic research that has steadily ... Cited by 513 - Related articles - BL Direct - All 14 versions
- ►ascopubs.org MG Kris, PJ Hesketh, MR Somerfield, P Feyer … - Journal of Clinical Oncology, 2006 - jco.ascopubs.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
PURPOSE: To update the 1999 American Society of Clinical Oncology guideline ... Cited by 173 - Related articles - All 17 versions
DB Smith, ES Newlands, GJS Rustin, RHJ … - The Lancet, 1991 - Elsevier Ondansetron, a serotonin antagonist, is effective in controlling the emesis
associated with cancer chemotherapy; however, emesis in patients receiving
high-dose cisplatin is poorly controlled by ondansetron alone. ... Cited by 140 - Related articles - All 6 versions
RM Navari, RR Reinhardt, RJ Gralla, MG Kris, … - The New England Journal of Medicine, 1999 - nejm.highwire.org Methods In a multicenter, double-blind, placebo-controlled trial involving 159
patients who had not previously received cisplatin, we evaluated the prevention
of acute emesis (occurring within 24 hours) and delayed emesis (occurring ... Cited by 138 - Related articles - BL Direct - All 4 versions
- ►ascopubs.org D Campos, JR Pereira, RR Reinhardt, C … - Journal of Clinical Oncology, 2001 - jco.ascopubs.org METHODS: This multicenter, double-blind, parallel-group trial in 351
cisplatin-naïve patients evaluated prevention of acute (0 to 24 hours) and
delayed emesis (primary efficacy parameter; days 2 to 5) after cisplatin ( ... Cited by 133 - Related articles - BL Direct - All 8 versions
- ►jcojournal.org [PDF] PJ Hesketh, WH Harvey, WG Harker, TM Beck, … - Journal of Clinical Oncology, 1994 - jcojournal.org Purpose: This study compares the efficacy and safety of ondansetron alone with
that of ondansetron plus dex- amethasone in the prevention of emesis induced by
high- dose cisplatin (- 100 mg/m2). Patients and Methods: This multicenter ... Cited by 111 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org [PDF] EA Perez, P Hesketh, J Sandbach, J Reeves, … - Journal of Clinical Oncology, 1998 - jco.ascopubs.org Purpose: The antiemetic effectiveness and safety of single-dose oral granisetron
were compared with intra- venous (IV) ondansetron in chemotherapy-naive pa-
tients who received moderately emetogenic chemother- apy. Patients and ... Cited by 103 - Related articles - BL Direct - All 7 versions
- ►ascopubs.org [PDF] R Navari, D Gandara, P Hesketh, S Hall, J … - Journal of Clinical Oncology, 1995 - jco.ascopubs.org Purpose: To compare the efficacy and safety of grani- setron and ondansetron,
serotonin (5-HT 3 ) receptor an- tagonists shown to be effective in the
prevention of che- motherapy-induced emesis. Patients and Methods: In a ... Cited by 101 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org [PDF] PJ Hesketh, DR Gandara - JNCI Journal of the National Cancer Institute, 1991 - jnci.oxfordjournals.org Despite a number of significant advances over the past decade, prevention and
treatment of chemotherapy-induced emesis remain formidable problems,
particularly with cisplatin-containing regimens. Nearly one third of ... Cited by 95 - Related articles - All 6 versions
